MEDNAX (MD) Tops Q2 EPS by 23c

MEDNAX (NYSE: MD) reported Q2 EPS of $0.32, $0.23 better than the analyst estimate of $0.09. Revenue for the quarter came in at $509 million versus the consensus estimate of $555.92 million.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Jefferies, UBS downgrade Victoria's Secret as rally leaves limited upside
• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance